Clinical outcomes of surgical embolectomy versus catheter-directed thrombolysis for acute limb ischemia: a nationwide cohort study

J Thromb Thrombolysis. 2022 Feb;53(2):517-522. doi: 10.1007/s11239-021-02532-1. Epub 2021 Aug 3.

Abstract

In Taiwan, the outcomes of acute limb ischemia have yet to be investigated in a standardized manner. In this study, we compared the safety, feasibility and outcomes of acute limb ischemia after surgical embolectomy or catheter-directed therapy in Taiwan. This study used data collected from the Taiwan's National Health Insurance Database (NHID) and Cause of Death Data between the years 2000 and 2015. The rate ratio of all-cause in-hospital mortality and risk of amputation during the same period of hospital stay were estimated using Generalized linear models (GLM). There was no significant difference in mortality risk between CDT and surgical intervention (9.5% vs. 10.68%, adjusted rate ratio (95% CI): regression 1.0 [0.79-1.27], PS matching 0.92 [0.69-1.23]). The risk of amputation was also comparable between the two groups. (13.59% vs. 14.81%, adjusted rate ratio (95% CI): regression 0.84 [0.68-1.02], PS matching 0.92 [0.72-1.17]). Age (p < 0.001) and liver disease (p = 0.01) were associated with higher mortality risks. Heart failure (p = 0.03) and chronic or end-stage renal disease (p = 0.03) were associated with higher amputation risks. Prior antithrombotic agent use (p = 0.03) was associated with a reduced risk of amputation. Both surgical intervention and CDT are effective and feasible procedures for patients with ALI in Taiwan.

Keywords: Acute limb ischemia; Embolectomy; Endovascular therapy; Thrombolysis.

MeSH terms

  • Acute Disease
  • Amputation, Surgical
  • Catheters
  • Cohort Studies
  • Embolectomy / adverse effects
  • Humans
  • Ischemia* / drug therapy
  • Ischemia* / surgery
  • Retrospective Studies
  • Risk Factors
  • Thrombolytic Therapy*
  • Treatment Outcome